Zycan 100mg 7 x 5mL
Randlab |
ZYCAN 7

Zycan 100mg 7 x 5mL

Prescription Product

This is a Schedule 4 (S4) Controlled Substance. Supply is strictly regulated under Australian law. Valid authorisation is required to purchase this product.

Enquire today to create an account

Register
Description
For treatment of lameness due to degenerative aseptic joint disease in horses.

Indications: Zycan is a Disease Modifying Osteoarthritis Drug (DMOAD) for the treatment and prevention of clinical signs attributable to degenerative and/or traumatic aseptic joint disease in horses. DMOADs are intended to prevent, retard or reverse the morphologic cartilaginous lesions associated with degenerative joint disease (DJD). PSGAGs, such as Zycan have been advocated for the (i) preventative treatment of joint disease (ii) chronic joint maintenance programs and (iii) post-operative care of horses returning to training following joint surgery.

Active Constituents: Polysulfated Glycosaminoglycan 100 mg/mL

Pack Size: 7 x 5mL Vials per carton
Additional Information
[Zebravet_Files]:
[Zebravet_Files]
Classification:
S4
Categorisation:
Prescription
Ingredients:
Polysulfated Glycosaminoglycan 100mg/mL